SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    H.A. Jinnah, Stewart A. Factor, Diagnosis and Treatment of Dystonia, Neurologic Clinics, 2015, 33, 1, 77

    CrossRef

  2. 2
    Elizabeth A. Ennis, Jane Wright, Cassandra L. Retzlaff, Owen B. McManus, Zhinong Lin, Xiaofang Huang, Meng Wu, Min Li, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, Randy D. Blakely, Identification and Characterization of ML352: A Novel, Noncompetitive Inhibitor of the Presynaptic Choline Transporter, ACS Chemical Neuroscience, 2015, 150202080035004

    CrossRef

  3. 3
    Sathya Vadivelu, Anne Stratton, Wendy Pierce, Pediatric Tone Management, Physical Medicine and Rehabilitation Clinics of North America, 2015, 26, 1, 69

    CrossRef

  4. 4
    K.L. Eskow Jaunarajs, P. Bonsi, M.F. Chesselet, D.G. Standaert, A. Pisani, Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia, Progress in Neurobiology, 2015,

    CrossRef

  5. 5
    Paul S. Larson, Deep Brain Stimulation for Movement Disorders, Neurotherapeutics, 2014, 11, 3, 465

    CrossRef

  6. 6
    Davin K. Quinn, Amanda Deligtisch, Caleb Rees, Aaron Brodsky, Daniel Evans, Mohamad Khafaja, Christopher C. Abbott, Differential Diagnosis of Psychiatric Symptoms After Deep Brain Stimulation for Movement Disorders, Neuromodulation: Technology at the Neural Interface, 2014, 17, 7
  7. 7
    Bettina Balint, Kailash P. Bhatia, Dystonia, Current Opinion in Neurology, 2014, 27, 4, 468

    CrossRef

  8. 8
    Deanna M. Thompson, Abigail N. Koppes, John G. Hardy, Christine E. Schmidt, Electrical Stimuli in the Central Nervous System Microenvironment, Annual Review of Biomedical Engineering, 2014, 16, 1, 397

    CrossRef

  9. 9
    Juan Ramirez-Castaneda, Joseph Jankovic, Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: A 20-year follow-up, Toxicon, 2014, 90, 344

    CrossRef

  10. 10
    Neepa Patel, Joseph Jankovic, Mark Hallett, Sensory aspects of movement disorders, The Lancet Neurology, 2014, 13, 1, 100

    CrossRef

  11. 11
    Mary Ann Thenganatt, Joseph Jankovic, Treatment of Dystonia, Neurotherapeutics, 2014, 11, 1, 139

    CrossRef

  12. 12
    Peter Hedera, Treatment of Wilson's disease motor complications with deep brain stimulation, Annals of the New York Academy of Sciences, 2014, 1315, 1
  13. 13
    D. Cristopher Bragg, Nutan Sharma, Update on Treatments for Dystonia, Current Neurology and Neuroscience Reports, 2014, 14, 6

    CrossRef

  14. 14
    H. A. Jinnah, Mahlon R. DeLong, Mark Hallett, The dystonias: Past, present, and future, Movement Disorders, 2013, 28, 7
  15. 15
    H. A. Jinnah, Alfredo Berardelli, Cynthia Comella, Giovanni DeFazio, Mahlon R. DeLong, Stewart Factor, Wendy R. Galpern, Mark Hallett, Christy L. Ludlow, Joel S. Perlmutter, Ami R. Rosen, The focal dystonias: Current views and challenges for future research, Movement Disorders, 2013, 28, 7